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Genetic susceptibility to chronic wasting disease in free-ranging white-
tailed deer: Complement component C1q and Prnp polymorphisms
Abstract
The genetic basis of susceptibility to chronic wasting disease (CWD) in free-ranging cervids is of great
interest. Association studies of disease susceptibility in free-ranging populations, however, face considerable
challenges including: the need for large sample sizes when disease is rare, animals of unknown pedigree create
a risk of spurious results due to population admixture, and the inability to control disease exposure or dose.
We used an innovative matched case–control design and conditional logistic regression to evaluate
associations between polymorphisms of complement C1q and prion protein (Prnp) genes and CWD
infection in white-tailed deer from the CWD endemic area in southcentral Wisconsin. To reduce problems
due to admixture or disease-risk confounding, we used neutral genetic (microsatellite) data to identify closely
related CWD-positive (n = 68) and CWD-negative (n = 91) female deer to serve as matched cases and
controls. Cases and controls were also matched on factors (sex, location, age) previously demonstrated to
affect CWD infection risk. For Prnp, deer with at least one Serine (S) at amino acid 96 were significantly less
likely to be CWD-positive relative to deer homozygous for Glycine (G). This is the first characterization of
genes associated with the complement system in white-tailed deer. No tests for association between any C1q
polymorphism and CWD infection were significant at p < 0.05. After controlling for Prnp, we found weak
support for an elevated risk of CWD infection in deer with at least one Glycine (G) at amino acid 56 of the
C1qC gene. While we documented numerous amino acid polymorphisms in C1q genes none appear to be
strongly associated with CWD susceptibility.
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1. Introduction
Chronic wasting disease (CWD) is a fatal transmissible spongi-
form encephalopathy (TSE) affecting free-ranging North American
cervids including elk (Cervus elaphus), moose (Alces alces), mule
deer (Odocoileus hemionus), and white-tailed deer (Odocoileus
virginianus) (Miller et al., 2000; Baeten et al., 2007). The probable
causative agent of TSEs is an abnormal isoform (PrPSc) of the
naturally occurring host prion protein (PrPc). The genetic basis of
susceptibility and disease progression in TSE diseases is of great
interest to breeding programs in domestic or captive animals (e.g.,
Cross and Bermester, 2002) and for predicting likely impacts of
disease in free-ranging populations. Most genetic susceptibility
work has focused on polymorphisms of the prion protein gene,
Prnp (e.g., Johnson et al., 2003, 2006; O’Rourke et al., 1999;
Perucchini et al., 2008;Wolfe et al., 2007). However, evidence from
transmission disequilibrium (Hernandez-Sanchez et al., 2002) and
quantitative trait loci (QTL) mapping studies (Lloyd et al., 2001;
Manolakou et al., 2001) and gene inactivation, knock-out, and
over-expression studies (e.g., Tamguney et al., 2008) suggest that a
number of other loci could be involved in TSE pathogenesis.
In CWD, infection is typically ﬁrst detectable in the peripheral
lymphoid tissues. This is like scrapie, where it is hypothesized that
PrPSc becomes established in the host, accumulates, and converts
normal PrPc protein to PrPSc before spreading to the central
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A B S T R A C T
The genetic basis of susceptibility to chronic wasting disease (CWD) in free-ranging cervids is of great
interest. Association studies of disease susceptibility in free-ranging populations, however, face
considerable challenges including: the need for large sample sizes when disease is rare, animals of
unknown pedigree create a risk of spurious results due to population admixture, and the inability to
control disease exposure or dose. We used an innovative matched case–control design and conditional
logistic regression to evaluate associations between polymorphisms of complement C1q and prion
protein (Prnp) genes and CWD infection in white-tailed deer from the CWD endemic area in south-
central Wisconsin. To reduce problems due to admixture or disease-risk confounding, we used neutral
genetic (microsatellite) data to identify closely related CWD-positive (n = 68) and CWD-negative (n = 91)
female deer to serve as matched cases and controls. Cases and controls were also matched on factors
(sex, location, age) previously demonstrated to affect CWD infection risk. For Prnp, deer with at least one
Serine (S) at amino acid 96were signiﬁcantly less likely to be CWD-positive relative to deer homozygous
for Glycine (G). This is the ﬁrst characterization of genes associated with the complement system in
white-tailed deer. No tests for association between any C1q polymorphism and CWD infection were
signiﬁcant at p < 0.05. After controlling for Prnp, we found weak support for an elevated risk of CWD
infection in deer with at least one Glycine (G) at amino acid 56 of the C1qC gene. While we documented
numerous amino acid polymorphisms in C1q genes none appear to be strongly associated with CWD
susceptibility.
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nervous system (Mabbot et al., 1998, 2000). These early stages of
peripheral TSE infection including PrPSc invasion, dissemination,
and replication likely involve activation of the complement system
(Sim et al., 2007). Support for complement system involvement in
early stages of TSE disease came from studies demonstrating
impeded accumulation of PrPSc in lymphoid tissue and delayed
spread of disease to the brain in mice deﬁcient in C3 or C1q (Klein
et al., 2001; Mabbott and Bruce, 2001). C1q recognizes and binds
mouse prion that has undergone conformational modiﬁcation that
may mimic infectious prion conformation (Blanquet-Grossard
et al., 2005; Dumestre-Perard et al., 2007), but will not bind to PrPc
(Dumestre-Perard et al., 2007). Additionally, Mitchell et al. (2007)
provided biochemical evidence that PrPSc not only binds with C1q,
but is capable of activating the classical pathway of the
complement system. An important hypothesized role for the
complement system in early TSE pathogenesis is facilitation of
PrPSc binding and delivery to follicular dendritic cells (FDCs) by
complement components C3 and C1q (Mabbott and Bruce, 2001).
Complement receptors CR1 and CR2 located on FDCs recognize and
trap these prion-complement complexes. Because FDCs play an
important role in antigen presentation for long-term immune
memory, PrPSc is hypothesized to persist and replicate on FDCs in
lymphoid tissues before spreading to the central nervous system.
Recently, Flores-Langarica et al. (2009) demonstrated that scrapie-
associated PrPSc uptake by conventional dendritic cells (CDCs),
known to be involved in early prion pathogenesis, is C1q-
dependent. Therefore, complement components are potentially
signiﬁcant factors modulating CWD pathogenesis.
Many polymorphisms of complement system components have
been characterized in humans and other mammals (e.g., Botto
et al., 1990; Petry et al., 1996; Moulds et al., 2001). Some of these
polymorphisms have been associated with disease susceptibility
or progression (e.g., Petry et al., 1995; Messias-Reason et al., 2003;
Cockburn et al., 2004). Given the apparent role of the complement
system in facilitating PrPSc invasion, associations between
complement gene polymorphisms and susceptibility or progres-
sion of CWD merit investigation.
Previous association studies in humans and domestic animals
have demonstrated that population admixture can produce
inconsistent and sometimes contradictory results (Deng, 2001;
Deng et al., 2001). Admixture arises when sampled populations are
composed of subpopulations with different disease-risk proﬁles.
For example, if a true susceptibility locus with a susceptibility
allele occurs at a higher frequency in one subpopulation, disease
susceptibility can be spuriously associated with any other loci and
alleles with higher (or lower) frequency in that subpopulation. In
free-ranging populations, non-random mating can lead to popula-
tion gene structure, or admixture, that can potentially confound
disease association studies. A major breakthrough in addressing
admixture problems was the development of the transmission
disequilibrium test (TDT; Spielman et al., 1993) and later variants
(Curtis, 1997; Schaid and Rowland, 1998; Spielman and Ewens,
1998). In such studies, comparisons are made among closely
related individuals (e.g., non-affected parents and affected off-
spring), which ensures similar genetic backgrounds. TDTs are
special cases of the matched case–control designs for which
conditional logistic regression is the appropriate method of
analysis (e.g., Waldman et al., 1998). Our study design builds on
this general approach in novel ways that are generally amenable
for disease association studies in free-ranging populations.
Our primary goal was to investigate the potential role of C1q
polymorphisms in CWD susceptibility in free-ranging white-tailed
deer from Wisconsin. As Prnp polymorphisms have been demon-
strated to be associated with CWD susceptibility (O’Rourke et al.,
1999, 2004; Johnson et al., 2003, 2006; Jewell et al., 2005; Fox et al.,
2006; Hamir et al., 2006; Keane et al., 2008a; but see Perucchini
et al., 2008), we simultaneously evaluated Prnp genotypes to
account for the effect of this gene in C1q analyses and to explore
potential inter-locus associations. Because, as discussed above,
non-random mating and unknown pedigrees in free-ranging
populations create a risk of spurious results due to admixture
we used microsatellite data to identify closely related CWD-
positive and CWD-negative deer to serve as matched cases and
controls. We also matched cases and controls for factors (sex,
location, age) previously demonstrated to affect CWD risk in our
study population (Joly et al., 2006; Grear et al., 2006; Osnas et al.,
2009). This innovative design allowed us to examine potential
associations of C1q and Prnp polymorphisms and CWD status with
relatively little risk of problems due to admixture or disease-risk
confounding.
2. Materials and methods
2.1. Study area and sample selection
CWD was ﬁrst detected in south-central Wisconsin in free-
ranging deer harvested in 2001. We obtained samples from female
white-tailed deer harvested from a285 km2 area of south-central
Wisconsin with the highest CWD prevalence (core-area) (5–7% of
adult deer) (Joly et al., 2006, Fig. 2). For each deer, the kill-location
reported by hunters was recorded as the Public Land Survey
System unit ‘‘section’’ (2.6 km2) and age was determined by
Department of Natural Resources staff. Though there is undoubt-
edly some error in both the location and age data, most error is
expected to be random with respect to disease status or
relatedness. Retropharyngeal lymph nodes and the obex portion
of the brainstemwere sent to theWisconsin Veterinary Diagnostic
Laboratory (WVDL) where CWD-infection status was determined
using immunohistochemistry (Johnson et al., 2006; Keane et al.,
2008b). We considered a deer to be CWD-positive if PrPCWD was
detected in lymph nodes or obex. Female deer were sampled
because they tend to have limited dispersal and spendmost of their
lives near their natal area (Marchinton and Hirth, 1984). Female
deer in close proximity, therefore, are expected to have relatively
similar exposure to prions.
We used a matched case–control design, matching controls to
cases based on their relatedness at neutral markers (microsatellite
loci) (e.g., Queller and Goodnight, 1989; Blouin et al., 1996).
Speciﬁcally, we used a maximum likelihood analysis (program
KinGroup; Konovalov et al., 2004) to identify non-infected
individuals that were signiﬁcantly more likely to be full siblings
of a CWD-infected deer than unrelated to it. While this analysis
does not guarantee that full siblings are identiﬁed, it does identify
deer that are statistically signiﬁcantly more likely to be very
closely related than unrelated. Relatedness was determined based
on the proportion of alleles the deer had in common at 14 unlinked
microsatellite loci (IGF-1 Kirkpatrick, 1992; OBCAM Fries et al.,
1993; CSN3, BM1225, BM6506 Bishop et al., 1994; Cervidae 1,
Cervidae 2 DeWoody et al., 1995; BM4107, BM4208 Talbot et al.,
1996; RT 7, RT 9, RT 23, RT 27Wilson et al., 1997; JP15, Pemberton
unpublished) relative to population allele frequencies generated
from 1400 female deer in the study area (Grear, 2006). Average
relatedness among female deer in the study area was low. Even for
deer harvested within the same section (2.6 km2) average
relatedness was only r = 0.004 (Grear, 2006). Relatedness among
female deer declined with increasing distance separating animals
such that average relatedness was not signiﬁcantly different from
r = 0 for deer separated by roughly 3.2 km or greater (Grear, 2006).
For each CWD-infected deer (case, n = 68) we selected at least
one non-infected deer (control, n = 91) that met the above
relatedness criterion. In addition, because prevalence, and thus
disease exposure, varies by spatial location and age (Grear et al.,
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2006; Joly et al., 2006; Osnas et al., 2009) each CWD-infected deer
was matched with a non-infected deer harvested within a 5.6 km
radius of the infected animal’s location, and when possible, of
similar age. We used this spatially explicit and relatedness-based
matched case control design to reduce potential confounding due
to admixture and to increase statistical power.
2.2. C1q gene sequencing
We sequenced the globular head regions of complement 1
subcomponent q polypeptides alpha, beta, and gamma (C1qA,
C1qB, C1qC) in CWD-positive and CWD-negative deer. C1q is
composed of 18 polypeptide chains: six A-chains, six B-chains, and
six C-chains. Each chain contains a collagen-like region located
near the N-terminal and a C-terminal globular region. The globular
heads of C1q are responsible for the recognition of a large variety of
ligands including prions (Gaboriauld et al., 2003, 2004). C1qA, B,
and C are relatively small (245–253 amino acids), they are encoded
within a small portion of the chromosome (between 2953 base
pairs (bp), 8557 bp and 4480 bp for C1qA, B, and C respectively),
and the entire protein is encoded within two exons for each gene.
The globular head region is contained within a single exon for each
of the coding regions for C1qA, B, and C.
Primers were designed from genomic DNA sequences predicted
to code for the C1q genes based on the genome of the domestic cow
(Bos taurus). Primers for each C1q genewere designed from aligned
B. taurus genomic and mRNA sequences to ﬂank the predicted
coding region for the globular domain of each C1q polypeptide.We
conﬁrmed the position of each globular head alignment with the
better-characterized human C1q polypeptide sequence. Accession
numbers for each C1q polypeptide in B. taurus and humans, PCR
sequencing primers for each C1q polypeptide in white-tailed deer,
and accession numbers for sequences identiﬁed in this study are
provided in Table 1.
Ampliﬁcation reaction conditions for each C1q gene were as
follows: 20 ng of genomic DNA, 200 mM dNTPs, 2.5 mM MgCl2,
2 pmol each primer, and 1 U ChromaTAQ (Denville Scientiﬁc, Inc.)
in ChromaTAQ Buffer in a total volume of 50 mL. During 30 cycles
of ampliﬁcation, primers annealed at 50 8C for C1qA and C1qB and
60 8C for C1qC. This ampliﬁcation generated a 672 bp fragment of
C1qA, a 700 bp fragment of C1qB, and a 900 bp fragment of C1qC.
PCR products were puriﬁed using Millipore Montage Centrifugal
PCR ﬁlters or the Qiagen Qiaquick PCR Puriﬁcation Kit. 20 ng of PCR
product was used as template in the sequencing reactions.
Sequences of C1qA were generated using the F2A primer,
sequences of C1qB were generated using the F11B primer, and
sequences of C1qC were generated using the BosQC2R primer
(Table 1).
For each C1q gene, PCR products were sequenced using an ABI
Prism 3700 DNA Analyzer at the Research Technology Support
Facility at Michigan State University. We trimmed sequences for
quality (Q > 20), aligned them, and used the chromatogramdata to
verify each polymorphic site. To determine the reading frame,
sample sequences were analyzed by a translated BLAST search
(blastx and tblastx). The reading frame used for analysis of the
C1qA globular head sequences was from base positions 1 through
423 on the plus strand. This reading frame was determined from
the high-scoring alignment with the predicted B. taurus C1qA
sequence (GenBank Accession number NP_001014945). The
reading frame used for analysis of C1qB globular head sequences
was from base position 9 through 537 on the minus strand. This
was determined from the high-scoring alignment with the
predicted B. taurus C1qB sequence (GenBank Accession number
XP_874787). The reading frame used for analysis of C1qC globular
head sequences was from base positions 2 through 508 on the plus
strand. This was determined from the high-scoring alignmentwith
the predicted B. taurus C1qC sequence (GenBank Accession number
XP_587039).
We performed translations and alignments on all unique
sequences usingMacVector.We grouped representative genotypes
for analysis using the program Collapse v1.1 (David Posada, 1999).
Sequences that contained double-peaks of approximately equal
height, indicating the presence of two different bases, were coded
with International Union of Pure and Applied Chemistry (IUPAC)
degeneracy codes and treated as polymorphisms. We replaced
each co-termination in the sequence, M (a/c), R (a/g), W (a/t), S (c/
g), and Y(c/t), with each of the two possible nucleotides and
translated them. The two resulting amino acid sequences were
aligned to one another to determine if a co-termination resulted in
an amino acid substitution in the predicted protein.
2.3. Prion gene sequencing
We sequenced the Prnp gene in all CWD-positive and CWD-
negative deer samples as described in detail in Johnson et al. (2003)
to verify previously observed patterns of association between Prnp
polymorphisms and CWD infection in Wisconsin deer (Johnson
et al., 2003, 2006) and to investigate potential interactions
between Prnp and C1q gene polymorphisms and CWD infection.
2.4. Statistical analyses of association between C1q and Prnp genes
and CWD infection
We considered three a priori nested models of gene association
with CWD infection. The ﬁrst two models (I, II) were speciﬁc to
each amino acid variable site (AAVS). Model I was a simple amino
acid presence/absence model that did not differentiate between
heterozygous and homozygous individuals. Model I was applied to
all AAVSs within each of the four genes (Prnp, C1qA, C1qB, C1qC).
Model II considered all observed amino acid dyads, within each
AAVS. In addition to being sensitive to heterozygosity, this model
was also sensitive to dose effects; differences between single dose
(heterozygous) and double dose (homozygous) states. Models I
and II were applied on an AAVS-speciﬁc basis. Because of the
importance of protein conformation in TSE diseases, it is plausible
that AAVSs might interact. Model III provided an extension of
Table 1
Accession numbers used in the design of primers to sequence C1q genes in white-tailed deer, primer pairs used to amplify C1q genes in this study, and accession numbers of
sequences in this study.
Gene Accession number
Bos taurus genomic DNA
Accession number
Bos taurus mRNA
Accession number
human mRNA
Primer pairs White-tailed deer Accession number
White-tailed deer
C1qA NC_007300 NM_001014945 NM_015991 F2A (50-TTA AAG GAG ACC AGG GCG AC-30) FJ775126–FJ775130
B5A (50-GAC ATG ATC TCC ATT TAG GC-30)
C1qB NC_007300 XM_869694 NM_000491 F11B (50-TGG AGC CCT ACT GTG TGC TTT G-30) FJ775013–FJ775065
R11B (50-CGT TAG CCA CCT CAA CGA GAA TG-30)
C1qC NC_931001 XM_587039 NM_172369 F1-CF (50-GGG AAT CGC TTT TTA GGG AAT TGG-30) FJ775066–FJ775125
BosQC2R (50-TCA CTG CCT TCC CAC CTG CTC TCT C-30)
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Model II that considered all amino acid dyads across all AAVSs
within a gene. Thus, Model III considered the genotype across all
AAVSs within a gene; hence one Model III analysis per gene.
For C1qA, B, and C, we also controlled for the effects of Prnp.
Speciﬁcally, we analyzed a special a priori case ofModel I wherewe
added an indicator of the presence or absence of Serine (S) at amino
acid 96 of the Prnp gene because of the support for the importance
of this amino acid position in CWD susceptibility and progression
(Johnson et al., 2006; Keane et al., 2008a). We report these results
with the Model I results.
Data were analyzed using conditional logistic regression
(Kleinbaum et al., 1982) by matching at least one control
(disease-negative deer) to each case (disease-positive deer) on
the basis of relatedness, harvest location, and age. This design
reduced the risk of obtaining spurious associations due to
population admixture or disease-risk confounding. Major distinc-
tions from the typical contingency table (cohort) approach used in
previous CWD studies are that case–control analyses are
performed within the matched sets which improves design
efﬁciency (smaller sample sizes required) for investigation of rare
diseases where controls are more common than cases (Kleinbaum
et al., 1982) and provides control of other factors that inﬂuence
disease risk. Conditional logistic regression was performed with
SAS PROC PHREG (SAS Institute Inc., Cary, NC). All reported p-
valueswere based on likelihood ratio statistics except in the case of
Model I analyses where Wald statistics were used. We report the
odds ratios (OR) and 95% conﬁdence intervals (95% CI) for the
amino acid effects for Model I.
Because other studies have reported a relationship between
disease progression (stage) and Prnp polymorphisms (e.g., Johnson
et al., 2006; Keane et al., 2008a), we tested for associations
between early disease stage (lymph node infection only) versus
later stage (lymph node and brain infection) and C1q and Prnp
polymorphisms using Fisher’s exact test (two-sided). We per-
formed these analyses on a gene-wise (Model III) basis.
We also tested for Hardy–Weinberg (HW) equilibrium at each
variable site for each gene for all animals combined and for CWD-
positive and CWD-negative animals separately. Departures from
HW equilibrium, especially in the positive group, may give
evidence for associations between genotypes and disease status.
3. Results
3.1. C1Q polymorphism
No deer were heterozygous at the nucleotide level across the
423 bp region of C1qA that we sequenced. Heterozygosity at the
nucleotide level was fairly common, however, in both the 542 bp
C1qB and 508 bp C1qC globular head regions though most
substitutions were silent when examined at the amino acid (AA)
Table 2
Disease association with the presence or absence of a particular amino acid at a speciﬁc amino acid variable site (corresponds to Model I in text).
Locus AAVSa AA Number positive Number positive p-Value Prnp-adjusted Odds ratio 95% CI
Prnp 95 Q 65 72 na na na na
No Q 0 0
H 0 1 0.994 na 0 0–1
No H 65 71
96 G 64 68 0.310 na 3.1 0.33–29.9
No G 1 4
S 9 31 0.002 na 0.22 0.08–0.59
No S 56 41
C1qA 4 N 60 79 0.896 0.995 0.82 0.04–18.4
No N 1 2
H 1 2 0.896 0.995 1.23 0.05–27.6
No H 60 79
118 K 59 78 0.239 0.995 0 0–1
No K 2 3
E 2 3 0.239 0.995 1 0–1
No E 59 78
C1qB 72 A 64 80 na na na na
No A 0 0
P 0 2 0.994 0.994 0 0–1
No P 64 78
164 I 63 80 0.994 0.994 0 0–1
No I 1 0
F 1 0 0.994 0.994 1 0–1
No F 63 80
170 L 64 80 na na na na
No L 0 0
H 1 1 0.809 0.282 1.4 0.08–25.0
No H 63 79
C1qC 30 E 67 82 na na na na
No E 0 0
V 4 1 0.341 0.994 3.00 0.30–30.2
No V 63 81
56 G 45 53 0.205 0.083 1.82 0.71–4.71
No G 22 29
S 33 39 0.567 0.530 0.74 0.33–1.65
No S 34 43
a Amino acid variable site.
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level. The reason for differences in heterozygosity among the C1q
genes is unknown.
For C1qA, we sequenced 142 deer (n = 61 case, n = 81 control).
We identiﬁed ﬁve unique nucleotide sequences producing variable
sites at AAs 4 and 118 (Tables 2 and 3) resulting in three different
predicted AA sequences each 140 AA long (Table 4). For C1qB, we
sequenced 144 deer (n = 64 case, n = 80 control). We identiﬁed 53
unique nucleotide sequences for C1qB producing variable sites at
AAs 72, 164, and 170 (Tables 2 and 3) resulting in four different
predicted AA sequences (176 AA) (Table 4). For C1qC, we
sequenced 149 deer (n = 67 case, n = 82 control). We identiﬁed
60 unique C1qC nucleotide sequences producing variable sites at
AAs 30 and 56 (Tables 2 and 3) resulting in four different predicted
AA sequences (169AA) (Table 4).
3.2. Prnp polymorphism
For Prnp, we sequenced 137 deer (n = 65 case, n = 72 control).
We identiﬁed variable sites at AAs 95 and 96 (Tables 2 and 3)
resulting in four different AA sequences (Table 4).
3.3. Associations between genotype and CWD infection
Association between Prnp polymorphisms and CWD infection
using conditional logistic regression analyses on matched cases
and controls conﬁrmed those documented by Johnson et al. (2006).
Speciﬁcally, deer with at least one Serine (S) at AA 96 were
signiﬁcantly less likely (OR = 0.22, 95% CI = 0.08–0.59, p = 0.002,
Table 2) to be CWD-positive (cases) relative to animals homo-
zygous for Glycine (G). There was no evidence for deviations from
HW equilibrium at any of the Prnp AAVSs (p > 0.3).
No tests for association between any C1q polymorphisms and
CWD infection were signiﬁcant at p < 0.05 (Tables 2–4). The
strongest statistical support for a C1q association was an increased
risk of CWD infection for deer with a Glycine (G) at AA 56 of the
C1qC gene after adjusting for the presence/absence of Serine (S) at
AA 96 of the Prnp gene (OR = 2.82, 95% CI = 0.85–9.32, p = 0.083,
Table 2). The apparently large odds ratio (OR = 3, Table 2) for the
presence/absence of Valine (V) at AA 30 of the C1qC gene does not
approach statistical signiﬁcance (p = 0.341), likely because of the
rarity of this polymorphism. Therewas also evidence for deviations
from HW equilibrium (heterozygote deﬁciency; p < 0.001) at
several C1q AAVSs (AA 4 C1qA; AAs 72, 164 C1qB; AA 56 C1qC) in
both CWD-positive and CWD-negative animals.
All Fisher’s exact tests for association between C1q or Prnp and
disease stage were non-signiﬁcant (all p > 0.05), although C1qA
was borderline at p = 0.055. Of the 56 CWD-positive animals for
whichwe had data on disease stage, none of the 44 later stage deer
(both lymph node and brain infection) were homozygous for
Asparagine (NN), Glutamic Acid (EE) or Histidine (HH), Glutamic
Acid (EE) while of the 12 early stage deer (lymph node infection
only), one each were NN, EE and HH, EE.
4. Discussion
Polymorphisms in complement genes can signiﬁcantly affect
disease pathogenesis (Maeurer et al., 1992; Petry et al., 1995;
Messias-Reason et al., 2003; Cockburn et al., 2004). For example, in
humans, mutations in C1q genes have been demonstrated to
modulate arthritis symptoms (Maeurer et al., 1992) and are
associated with systemic lupus erythematosus (Petry et al., 1995).
The complement system appears to play an important role in early
TSE pathogenesis (Mabbott and Bruce, 2001; Flores-Langarica
et al., 2009). Using intraperitoneal inoculations of low dilutions of
PrPSc in mice, Klein et al. (2001) discovered that while 100% of
control animals were susceptible to infection, none of the C1q
deﬁcient animals became infected (Klein et al., 2001, Table 1).
Besides complete gene deﬁciency, polymorphisms could inﬂuence
the ability of C1q to bind and deliver PrPSc to follicular dendritic
cells or to participate in PrPSc uptake in common dendritic cells,
possibly affecting the rate of PrPSc invasion and the progression of
disease. These data are the ﬁrst characterization of genes
associated with the complement system in white-tailed deer
and the ﬁrst assessment of the role of complement gene
polymorphism in TSE susceptibility. While we detected numerous
amino acid polymorphisms in the globular head regions of C1qA, B,
and C genes, most were quite rare and none were as strongly
associated with CWD infection as the polymorphism at AA 96 in
the Prnp gene.
The relatively intensive harvest of deer in our study population
(Blanchong et al., 2006) has led to a young age structure in which
Table 3
Disease association with the presence or absence of a particular amino acid pair
(genotype) at a speciﬁc amino acid variable site (corresponds to Model II in text).
Gene AAVSa Genotypes Number
positive
Number
negative
p-Value
Prnp 95 QQ 65 71 0.239
QH 0 1
96 GG 56 41 0.002
GS 8 27
SS 1 4
C1qA 4 NN 60 79 0.896
HH 1 2
118 KK 59 78 0.239
EE 2 3
C1qB 72 AA 64 78 0.096
AP 0 2
164 II 63 80 0.138
FF 1 0
170 LL 63 79 0.810
LH 1 1
C1qC 30 EE 63 81 0.306
EV 4 1
56 GG 34 43 0.427
GS 11 10
SS 22 29
a Amino acid variable site.
Table 4
Disease association for unique genotypes across all amino acid variable sites for
each gene (corresponds to Model III in text).
Locus AAVSa Unique
genotypes
Number
positive
Number
negative
p-Value
Prnp 95, 96 QQ, GG 56 40 0.001
QQ, GS 8 27
QQ, SS 1 4
QH, GG 0 1
C1qA 4, 118 NN, KK 59 78 0.333
NN, EE 1 1
HH, EE 1 2
C1qB 72, 164, 170 AA, II, LL 62 77 0.170
AA, II, LH 1 1
AA, FF,LL 1 0
AP, II, LL 0 2
C1qC 30, 56 EE, GG 33 43 0.426
EE, GS 9 9
EE, SS 21 29
EV, GG 1 0
EV, GS 2 1
EV, SS 1 0
a Amino acid variable site.
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deer appear to successfully breedevenwhenvery young (Blanchong
etal., unpublished).Becauseyounganimals areat signiﬁcantly lower
risk of CWD infection than older animals (Grear et al., 2006; Osnas
et al., 2009) many deer are likely to reproduce before they become
infected. Reproduction prior to infection will reduce the effective-
ness of disease as a selective agent. In addition, because clinical
symptoms of CWD in infected animals take several months to years
to appear (Williams, 2005), it is very likely that infected animals
produce offspring prior to dying from CWD further reducing
selection pressure and limiting gene frequency changes at
disease-associated loci over time. In addition to the likelihood that
deer breed before infection or clinical signs of disease, CWD
prevalence in our study area is fairly low further limiting the
opportunity for selection for disease-resistance to shift gene
frequencies. As such, weak associations between C1q polymorph-
isms and CWD susceptibility may not be detectable in this
population. Associations between C1q polymorphisms and CWD
susceptibility might be detectable in areas where the disease has
been established for a longer time, disease is at higher prevalence,
and age structure is more normally distributed such that younger
deer may be less likely to breed (e.g., Colorado or Wyoming).
Identifying the genetic basis for heterogeneity in disease
susceptibility or progression can improve our understanding of
individual variation in disease susceptibility in both free-ranging
and captive populations. What this individual variation in disease
susceptibility means for the trajectory of disease in a population,
however, is not straightforward. For example, the greater, but not
complete, resistance to CWD in deer with at least one Serine (S) at
amino acid 96 of the Prnp gene appears to be associated with
slower progression of disease (e.g., Johnson et al., 2006; Keane
et al., 2008a). If slower disease progression results in longer-lived,
infected deer with longer periods of infectiousness, resistancemay
lead to increased disease transmission rates, higher prion
concentrations in the environment, and increased prevalence, as
has been observed in some captive deer herds (Miller et al., 2006;
Keane et al., 2008a). Alternatively, if the slower progression of
disease in resistant deer is not associated with longer periods of
infectiousness, but might instead indicate a higher dose of PrPCWD
is required for infection, transmission rates in the population could
decline especially if, as in Wisconsin, deer suffer high rates of
mortality from other sources (e.g., hunting). Clearly, determining
the relationship between genetic susceptibility to infection, dose
requirements, disease progression, and the period of PrPCWD
infectiousness are key components for understanding the con-
sequences of CWD to free-ranging populations.
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